[Comparison of 3 therapeutic regimens in paucibacillary leprosy. Preliminary note].
Between 1980 et 1983 all PB patients presenting at the Institut Marchoux, Bamako, took part in a prospective randomized therapeutic trial and were allocated to one of the following regimens: DDS 100 mg 7/7 3 years, RMP 900 mg 1/7 8 doses, RMP 900 mg 7/7 12 doses. At this moment 24, 29 and 22 patients respectively have been followed for periods of 24 to 56 months. With the exception of some irregular drug intake in the DDS patients followed either by relapse or delay in improvement, the efficacity as judged by histopathological examinations did not reveal any difference between the regimens. The study continues.
Husser
J A
JA
Baquillon
G
G
Pattyn
S R
SR
D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008302:Mali; D011446:Prospective Studies; D011897:Random Allocation; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*
D003622:Dapsone; D012293:Rifampin
Comparaison de trois régimes thérapeutiques dans la lèpre paucibacillaire. Note préliminaire.